Ex-Cel­gene deal­mak­er George Golumbes­ki joins up to guide Car­rick on its can­cer drug quest — and maybe an IPO as well

Dublin-based Car­rick Ther­a­peu­tics has picked up a clin­i­cal stage can­cer drug, as well as a well-con­nect­ed new chair­man of the board.

Ex-Cel­gene deal­mak­er George Golumbes­ki has added to his con­sid­er­able range of ac­tiv­i­ties by tak­ing the chair at Car­rick, which hit the scene two years ago with a $95 mil­lion start­up round and plans to scoop up a pipeline through a se­ries of part­ner­ing deals.

Speak­ing of which.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.